Ubs Asset Management Americas Inc Bio N Tech Se Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Bio N Tech Se stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 221,080 shares of BNTX stock, worth $24.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

221,080

Previous 184,334 19.93%

Holding current value

$24.1 Million

Previous $21.9 Million 15.07%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$99.72 - $122.68 $3.66 Million - $4.51 Million	36,746 Added 19.93%	221,080 $25.2 Million
Q3 2024 Nov 14, 2024	SELL	$78.36 - $124.66 $3.7 Million - $5.89 Million	-47,213 Reduced 20.39%	184,334 $21.9 Million
Q2 2024 Aug 13, 2024	BUY	$80.36 - $102.87 $1.41 Million - $1.81 Million	17,558 Added 8.21%	231,547 $18.6 Million
Q1 2024 May 15, 2024	SELL	$88.96 - $112.35 $69.5 Million - $87.8 Million	-781,264 Reduced 78.5%	213,989 $19.7 Million
Q4 2023 Feb 14, 2024	BUY	$90.91 - $112.75 $12.5 Million - $15.5 Million	137,115 Added 15.98%	995,253 $105 Million
Q3 2023 Nov 13, 2023	BUY	$98.5 - $125.08 $39.1 Million - $49.7 Million	397,315 Added 86.22%	858,138 $93.2 Million
Q1 2023 May 15, 2023	SELL	$122.57 - $153.67 $2.39 Million - $2.99 Million	-19,478 Reduced 4.06%	460,823 $57.4 Million
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $16.7 Million - $26.2 Million	140,865 Added 41.5%	480,301 $72.2 Million
Q3 2022 Nov 14, 2022	BUY	$127.65 - $183.11 $17.2 Million - $24.7 Million	134,663 Added 65.76%	339,436 $45.8 Million
Q2 2022 Aug 12, 2022	BUY	$123.25 - $186.24 $3.04 Million - $4.6 Million	24,700 Added 13.72%	204,773 $30.5 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $3.59 Million - $6.6 Million	28,446 Added 18.76%	180,073 $30.7 Million
Q4 2021 Feb 14, 2022	BUY	$216.64 - $362.52 $12.7 Million - $21.2 Million	58,400 Added 62.64%	151,627 $39.1 Million
Q3 2021 Nov 15, 2021	SELL	$205.93 - $447.23 $6.85 Million - $14.9 Million	-33,271 Reduced 26.3%	93,227 $25.5 Million
Q2 2021 Aug 16, 2021	SELL	$113.32 - $241.49 $22.8 Million - $48.6 Million	-201,340 Reduced 61.41%	126,498 $28.3 Million
Q1 2021 May 14, 2021	BUY	$85.73 - $119.5 $3.99 Million - $5.56 Million	46,556 Added 16.55%	327,838 $35.8 Million
Q4 2020 Mar 01, 2021	BUY	$72.71 - $129.54 $10.3 Million - $18.3 Million	141,090 Added 100.64%	281,282 $22.9 Million
Q3 2020 Nov 13, 2020	SELL	$57.81 - $104.17 $3.59 Million - $6.46 Million	-62,014 Reduced 30.67%	140,192 $9.71 Million
Q2 2020 Aug 14, 2020	BUY	$38.58 - $66.74 $7.8 Million - $13.5 Million	202,206 New	202,206 $13.5 Million

Others Institutions Holding BNTX

# of Institutions

363

Shares Held

39.6M

Call Options Held

3.01M

Put Options Held

2.01M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $26.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Bio N Tech Se Transaction History